Publikationsliste
Aus 2025:
Covalent Targeting Leads to the Development of a LIMK1 Isoform-Selective Inhibitor.
Mandel S, Hanke T, Prendiville N, Baena-Nuevo M, Berger LM, Farges F, Schwalm MP, Berger BT, Kraemer A, Elson L, Saraswati H, Abdul Azeez KR, Dederer V, Mathea S, Corrionero A, Alfonso P, Keller S, Gstaiger M, Krause DS, Müller S, Röhm S, Knapp S. J Med Chem. 2025 Jul 24;68(14):15026-15049. doi: 10.1021/acs.jmedchem.5c01204. Epub 2025 Jul 2. PMID: 40598933 Free PMC article.
The role of the extracellular matrix protein SPOCK2 for bone physiology and hematopoiesis.
Kumar R, Das S, Minka W, Reiter C, Pereira R, Fuhrmann D, Schneider R, Seshire A, Reusch C, Conche C, Imkeller K, Pajevic PD, Krause DS. Bone. 2025 Sep;198:117539. doi: 10.1016/j.bone.2025.117539. Epub 2025 May 20. PMID: 40403823
Repurposing of the RIPK1-Selective Benzo[1,4]oxazepin-4-one Scaffold for the Development of a Type III LIMK1/2 Inhibitor.Mandel S, Hanke T, Mathea S, Chatterjee D, Saraswati H, Berger BT, Schwalm MP, Yamamoto S, Tawada M, Takagi T, Ahmed M, Röhm S, Corrionero A, Alfonso P, Baena M, Elson L, Menge A, Krämer A, Pereira R, Müller S, Krause DS, Knapp S. ACS Chem Biol. 2025 May 16;20(5):1087-1098. doi: 10.1021/acschembio.5c00097. Epub 2025 Apr 14. PMID: 40227881
Aus 2024:
Minciacchi VR, Bravo J, Karantanou C, Pereira RS, Zanetti C, Kumar R, Thomasberger N, Llavona P, Krack T, Bankov K, Meister M, Hartmann S, Maguer-Satta V, Lefort S, Putyrski M, Ernst A, Huntly BJP, Meduri E, Ruf W, Krause DS.Nat Commun. 2024 Nov 20;15(1):10059. doi: 10.1038/s41467-024-54361-4. PMID: 39567540 Free PMC article.
Adult skull bone marrow is an expanding and resilient haematopoietic reservoir.
Koh BI, Mohanakrishnan V, Jeong HW, Park H, Kruse K, Choi YJ, Nieminen-Kelhä M, Kumar R, Pereira RS, Adams S, Lee HJ, Bixel MG, Vajkoczy P, Krause DS, Adams RH. Nature. 2024 Dec;636(8041):172-181. doi: 10.1038/s41586-024-08163-9. Epub 2024 Nov 13. PMID: 39537918 Free PMC article
Differential inflammatory conditioning of the bone marrow by acute myeloid leukemia and its impact on progression.Minciacchi VR, Karantanou C, Bravo J, Pereira RS, Zanetti C, Krack T, Kumar R, Bankov K, Hartmann S, Huntly BJP, Meduri E, Ruf W, Krause DS. Blood Adv. 2024 Oct 8;8(19):4983-4996. doi: 10.1182/bloodadvances.2024012867.PMID: 38996202
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes.Windisch R, Soliman S, Hoffmann A, Chen-Wichmann L, Danese A, Vosberg S, Bravo J, Lutz S, Kellner C, Fischer A, Gebhard C, Redondo Monte E, Hartmann L, Schneider S, Beier F, Strobl CD, Weigert O, Peipp M, Schündeln M, Stricker SH, Rehli M, Bernhagen J, Humpe A, Klump H, Brendel C, Krause DS, Greif PA, Wichmann C. Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2312499121. doi: 10.1073/pnas.2312499121. Epub 2024 Jun 10. PMID: 38857395
Cyclophilin A supports translation of intrinsically disordered proteins and affects haematopoietic stem cell ageing.Maneix L, Iakova P, Lee CG, Moree SE, Lu X, Datar GK, Hill CT, Spooner E, King JCK, Sykes DB, Saez B, Di Stefano B, Chen X, Krause DS, Sahin E, Tsai FTF, Goodell MA, Berk BC, Scadden DT, Catic A. Nat Cell Biol. 2024 Apr;26(4):593-603. doi: 10.1038/s41556-024-01387-x. Epub 2024 Mar 29. PMID: 38553595